136 related articles for article (PubMed ID: 24335743)
1. Human papillomavirus vaccine administration among Medicaid providers who consistently recommended vaccination.
Malo TL; Staras SA; Bynum SA; Giuliano AR; Shenkman EA; Vadaparampil ST
Sex Transm Dis; 2014 Jan; 41(1):24-8. PubMed ID: 24335743
[TBL] [Abstract][Full Text] [Related]
2. Do Florida Medicaid providers' barriers to HPV vaccination vary based on VFC program participation?
Malo TL; Hassani D; Staras SA; Shenkman EA; Giuliano AR; Vadaparampil ST
Matern Child Health J; 2013 May; 17(4):609-15. PubMed ID: 22569945
[TBL] [Abstract][Full Text] [Related]
3. Provider factors associated with disparities in human papillomavirus vaccination among low-income 9- to 17-year-old girls.
Vadaparampil ST; Staras SA; Malo TL; Eddleton KZ; Christie J; Rodriguez M; Giuliano AR; Shenkman EA
Cancer; 2013 Feb; 119(3):621-8. PubMed ID: 23341308
[TBL] [Abstract][Full Text] [Related]
4. Correlates of human papillomavirus vaccine coverage: a state-level analysis.
Moss JL; Reiter PL; Brewer NT
Sex Transm Dis; 2015 Feb; 42(2):71-5. PubMed ID: 25585064
[TBL] [Abstract][Full Text] [Related]
5. Florida physicians' reported use of AFIX-based strategies for human papillomavirus vaccination.
Kasting ML; Christy SM; Sutton SK; Lake P; Malo TL; Roetzheim RG; Schechtman T; Zimet GD; Walkosz BJ; Salmon D; Kahn JA; Giuliano AR; Vadaparampil ST
Prev Med; 2018 Nov; 116():143-149. PubMed ID: 30219689
[TBL] [Abstract][Full Text] [Related]
6. Examining HPV Vaccination Practices and Differences Among Providers in Virginia.
Alcalá HE; Maxwell GL; Lindsay B; Keim-Malpass J; Mitchell EM; Balkrishnan R
J Cancer Educ; 2020 Feb; 35(1):159-164. PubMed ID: 30520008
[TBL] [Abstract][Full Text] [Related]
7. The Role of Physician Recommendations and Public Policy in Human Papillomavirus Vaccinations.
Moghtaderi A; Adams S
Appl Health Econ Health Policy; 2016 Jun; 14(3):349-59. PubMed ID: 26873090
[TBL] [Abstract][Full Text] [Related]
8. Providers' beliefs about the effectiveness of the HPV vaccine in preventing cancer and their recommended age groups for vaccination: Findings from a provider survey, 2012.
Berkowitz Z; Malone M; Rodriguez J; Saraiya M
Prev Med; 2015 Dec; 81():405-11. PubMed ID: 26598805
[TBL] [Abstract][Full Text] [Related]
9. Pediatricians' intention to administer human papillomavirus vaccine: the role of practice characteristics, knowledge, and attitudes.
Kahn JA; Zimet GD; Bernstein DI; Riedesel JM; Lan D; Huang B; Rosenthal SL
J Adolesc Health; 2005 Dec; 37(6):502-10. PubMed ID: 16310128
[TBL] [Abstract][Full Text] [Related]
10. Prevalence and predictors of human papillomavirus vaccination in adolescent girls.
Palli SR; Mehta S; Aparasu RR
J Am Pharm Assoc (2003); 2012; 52(1):52-8. PubMed ID: 22257616
[TBL] [Abstract][Full Text] [Related]
11. Differences in Human Papillomavirus Vaccination Among Adolescent Girls in Metropolitan Versus Non-metropolitan Areas: Considering the Moderating Roles of Maternal Socioeconomic Status and Health Care Access.
Monnat SM; Rhubart DC; Wallington SF
Matern Child Health J; 2016 Feb; 20(2):315-25. PubMed ID: 26511129
[TBL] [Abstract][Full Text] [Related]
12. Identifying human papillomavirus vaccination practices among primary care providers of minority, low-income and immigrant patient populations.
Bruno DM; Wilson TE; Gany F; Aragones A
Vaccine; 2014 Jul; 32(33):4149-54. PubMed ID: 24886959
[TBL] [Abstract][Full Text] [Related]
13. Predictors of provider recommendation for HPV vaccine among young adult men and women: findings from a cross-sectional survey.
Gerend MA; Shepherd MA; Lustria ML; Shepherd JE
Sex Transm Infect; 2016 Mar; 92(2):104-7. PubMed ID: 26297720
[TBL] [Abstract][Full Text] [Related]
14. Cost-effectiveness analysis of introducing universal human papillomavirus vaccination of girls aged 11 years into the National Immunization Program in Brazil.
Novaes HM; de Soárez PC; Silva GA; Ayres A; Itria A; Rama CH; Sartori AM; Clark AD; Resch S
Vaccine; 2015 May; 33 Suppl 1():A135-42. PubMed ID: 25919154
[TBL] [Abstract][Full Text] [Related]
15. Correlates of human papillomavirus vaccination rates in low-income, minority adolescents: a multicenter study.
Perkins RB; Brogly SB; Adams WG; Freund KM
J Womens Health (Larchmt); 2012 Aug; 21(8):813-20. PubMed ID: 22860770
[TBL] [Abstract][Full Text] [Related]
16. Disparities in Provider Recommendation of Human Papillomavirus Vaccination for U.S. Adolescents.
Mohammed KA; Geneus CJ; Osazuwa-Peters N; Adjei Boakye E; Tobo BB; Burroughs TE
J Adolesc Health; 2016 Nov; 59(5):592-598. PubMed ID: 27506278
[TBL] [Abstract][Full Text] [Related]
17. Characterizing safety-net providers' HPV vaccine recommendations to undecided parents: A pilot study.
Shay LA; Street RL; Baldwin AS; Marks EG; Lee SC; Higashi RT; Skinner CS; Fuller S; Persaud D; Tiro JA
Patient Educ Couns; 2016 Sep; 99(9):1452-60. PubMed ID: 27401828
[TBL] [Abstract][Full Text] [Related]
18. Factors associated with initiation and completion of human papillomavirus vaccine series among young women enrolled in Medicaid.
Cook RL; Zhang J; Mullins J; Kauf T; Brumback B; Steingraber H; Mallison C
J Adolesc Health; 2010 Dec; 47(6):596-9. PubMed ID: 21094437
[TBL] [Abstract][Full Text] [Related]
19. The estimated impact of human papillomavirus vaccine coverage on the lifetime cervical cancer burden among girls currently aged 12 years and younger in the United States.
Chesson HW; Ekwueme DU; Saraiya M; Dunne EF; Markowitz LE
Sex Transm Dis; 2014 Nov; 41(11):656-9. PubMed ID: 25299411
[TBL] [Abstract][Full Text] [Related]
20. Factors associated With Medicaid providers' recommendation of the HPV vaccine to low-income adolescent girls.
Bynum SA; Staras SA; Malo TL; Giuliano AR; Shenkman E; Vadaparampil ST
J Adolesc Health; 2014 Feb; 54(2):190-6. PubMed ID: 24064282
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
